INTRODUCTION
Loss of skeletal muscle mass (atrophy) occurs following an absence of muscle loading and recruitment (unloading/disuse, neural damage), as a consequence of disease (cancer, burn injury, heart failure, sepsis, AIDS, etc.), or in conjunction with aging (sarcopenia). The decrement in muscle mass impairs recovery, increases morbidity, and reduces quality of life. Satellite cells, skeletal muscle-resident stem cells, are key mediators of muscle plasticity through contributions to myofiber hypertrophy. Additionally, they are indispensable for myofiber regeneration/repair following injury. Recent clinical and preclinical studies have shown perturbations in satellite cell activity and abundance that accompany muscle atrophy. However, controversy surrounds the role of satellite cells in mediating muscle atrophy resulting from disuse and during illness, as well as their role in promoting restoration of atrophied muscle. In this review, we will explore recent findings concerning the role of satellite cells during atrophy, with an emphasis unloading through hind limb suspension (HLS), yielding rapid atrophy over 1-2 weeks. Nakanishi et al.
[2] exposed adult female rats to 14 days of bilateral HLS [2] . Myosin heavy chain (MHC) type 1 and 2 fibers of the soleus muscle exhibited atrophy in concert with reduced satellite cell content. Pax7þ and MyoDþ satellite cell abundance was reduced in HLS animals, as was the frequency of myogeninþ differentiating satellite cells. These findings suggest muscle disuse impairs satellite cell proliferation and differentiation, and reduces general abundance. A similar study employed 10 days of unloading in adult male rats, studying atrophy in the tibialis anterior muscle [3] . Atrophy was present only in MHC type 2x and 2b fibers in the tibialis anterior, with reduced satellite cell content only associated with these fiber types [3] . This evidence suggests that reduced satellite cell content and function may hinder the regenerative and regrowth responses that ordinarily follow periods of disuse. Similar decrements in oxidative (soleus) [ 
KEY POINTS
Recent studies have shown perturbations in skeletal muscle satellite cell activity and abundance that accompany atrophy and functional decline.
Conflicting evidence exists as to the contribution of satellite cells to unloading and denervation-induced muscle atrophy.
Traumatic injury and illness induces robust systemic inflammation that likely contributes to impaired myogenesis and promotes the onset of muscle wasting.
Age-related muscle atrophy is associated with diminished activity and decreased abundance of satellite cells; however, it is unlikely that reduced satellite cell density and fusion contribute directly to the onset of sarcopenia under sedentary conditions.
SATELLITE CELL ALTERATIONS DURING CHRONIC AND ACUTE ILLNESS

Chronic illness-induced atrophy
The prevalence of chronic conditions such as cancer, diabetes, and congestive heart failure (CHF) continues to rise globally, and recent evidence highlights dysregulated satellite cell activity contributing to muscle atrophy in the presence of these conditions. Brzeszczyń ska et al. [12] showed reduced myogenin (terminal satellite cell differentiation marker) expression in cancer patients experiencing weight loss compared with healthy controls. Proinflammatory cytokines were also elevated in cancer patients [12] . Specifically, IL-6 impedes satellite cell differentiation; however, transient inhibition of Stat3, which is downstream of IL-6 signaling, promoted satellite cell expansion, and skeletal muscle repair postinjury [13] .
Impaired satellite cell differentiation is also observed in children with type 1 diabetes, and a mouse model of the condition Alternatively, over-activation of the reninangiotensin system contributes to cachectic muscle wasting in chronic conditions such as CHF and chronic kidney disease. Recently, Yoshida et al. [15 && ] showed that angiotensin type 1 and 2 receptors (AT1R, AT2R) regulate different stages of satellite cell proliferation and activation. In a mouse model of CHF, there was a marked reduction in muscle regeneration that was associated with attenuated AT2R expression [15 && ]. Eloquent promoter reporter analysis experiments identified intron 2 of AT2R as a transcriptional enhancer element that promotes satellite cell differentiation. CHF, however, suppresses the AT2R intron 2 enhancer activity, leading to diminished AT2R expression that likely contributes to impaired satellite cell differentiation and muscle regeneration [15 && ]. Altered AT2R expression may also occur in other chronic conditions (chronic obstructive pulmonary disease, chronic kidney disease, and so on) characterized by perturbations in the renin-angiotensin system, and offers a new target to restore proper satellite cell activity levels to combat pervasive muscle wasting.
Acute trauma and illness-induced atrophy
Critically ill individuals and acute trauma survivors often experience weakness and functional disability that can persist for years; elucidating the underlying cellular mechanisms that contribute to the rapid loss of muscle mass and function is critical to developing evidence-based therapeutic strategies. Dos Santos et al. [16] showed rapid and robust atrophy in patients 7 days following intensive care unit (ICU) discharge, and $75% of patients demonstrated persistent atrophy at 6 months following ICU discharge. Notably, critically ill patients showed elevated protein degradation through the ubiquitin-proteasome system, but not the autophagosomal-lysosomal system at 7 days postdischarge, but neither the ubiquitin-proteasome nor the autophagosomal-lysosomal system was related to atrophy at 6 months postdischarge [16] . However, decreased satellite cell abundance was observed at both 7 days and 6 months postdischarge, and was associated with persistent muscle atrophy [16] . Specifically, in the 75% of patients who failed to regain quadriceps muscle size, reduced satellite cell density was observed compared with the 25% of patients who restored their atrophied muscle mass [16] . Whereas previous work has shown no deleterious effect on regrowth following atrophy in SC-dep healthy mice [17] , the diminished satellite cell content in critically ill patients may play a causative role in poor muscle regrowth and sustained atrophy.
Similarly, in pediatric patients who have suffered a severe burn injury (more than 30% total body surface area), we observed reductions in satellite cell abundance [18 & ]. Indices of muscle regeneration and myonuclear apoptosis were elevated in burn patients [18 & ], both of which require satellite cell activity/fusion for repair. Whereas a subset of satellite cells showed evidence of proliferation (Ki67þ satellite cells undergoing mitosis) in burn patients, there was also evidence of satellite cell apoptosis that was significantly correlated with burn severity [18 & ]. Burn injury-induced myounclear turnover and myofiber regeneration require adequate and appropriate satellite cell activity and suggest a critical role for satellite cells in skeletal muscle atrophy and recovery following burn trauma. Similar findings reported by Song et al. [19 && ] show activation of satellite cells alongside myonuclear apoptosis in mouse muscle following a scald burn. However, the observed myogenesis postscald likely does not counterbalance the increased cell death Satellite cells, atrophy and illness McKenna and Fry after burn, contributing to burn-induced cachexia [19 && ]. Additionally, inflammation through tumor necrosis factor-a may attenuate the myogenic response to a thermal injury, mitigating the recovery of atrophied muscle [19 && ]. Findings from Corrick et al. [20] further support that satellite cell terminal differentiation is impaired postburn. When primary human skeletal muscle satellite cells were differentiated to myotubes in vitro and exposed to serum from burn patients, there was a reduction in myogenic fusion signaling and impairment of myogenesis (fewer nuclei per myotube) [20] . Diminished myonuclear accrual during differentiation was also associated with reduced myotube size, emphasizing the integral role of satellite cells in the recovery of lean muscle following a burn injury [20] . Results from these recent studies highlight the need for a greater understanding of burn-induced dysregulation of satellite cell activity to identify targeted therapies to promote muscle recovery.
Acute orthopedic injuries, such as those involving the rotator cuff or anterior cruciate ligament (ACL), can include prolonged muscle atrophy that results in pain, weakness, loss of function, and biomechanical instability. Following ACL injury, Noehren and colleagues reported reduced abundance of satellite cells in the injured limb compared with participants' noninjured limb -which was not restored following surgical reconstruction and rehabilitation [21 && ,22] . Reported satellite cell deficits were also associated with quadriceps muscle atrophy and additional morphological maladaptations following ACL injury [21 && ]. Reductions in satellite cell density have also been reported in atrophied/functionally impaired supraspinatus muscle following rotator cuff injury [23] . Recently, Gigliotti et al. [23] showed that satellite cells exhibited low basal levels of proliferative activity (Pax7þ cells in S-phase) in supraspinatus muscles following rotator cuff injury versus control deltoid muscles. Another study from the same group exposed isolated fibers of post-rotator cuff injury supraspinatus biopsies to isosorbide dinitrate (nitric oxide donor drug) [23] . Drug exposure induced greater satellite cell proliferation in vitro [24] . Enhancement of satellite cell proliferative capacity post-rotator cuff injury may enable regeneration and improve successful reversal of muscle atrophy following rotator cuff surgical repair [24] . Although these studies demonstrate reduced satellite cell density following an orthopedic injury, further work is needed to define the underlying mechanisms behind these reductions.
CONTRIBUTION OF SATELLITE CELLS TO SARCOPENIA
Several recent review articles provide in-depth assessment of cell-intrinsic and cell-extrinsic modifications to satellite cells that contribute to their functional decline with advancing age [25] [26] [27] . Agerelated declines in satellite cell abundance have also been well documented in rodents 
CONCLUSION
Significant recent attention has been paid to the regulatory role of satellite cells in mediating skeletal muscle atrophy and recovery (Fig. 1) . Clear deficits in functional activity and abundance have emerged in both acute and chronic clinical models that present with significant muscle wasting. However, a causal role for satellite cells in mediating the various atrophic phenotypes remains unsettled. 
